Patients experiencing with both HIV and cancer face a complex treatment challenge. The interplay between these two diseases can lead to unique clinical manifestations and present significant difficulties in achieving optimal results. Pharmacological interactions offer a promising strategy for improving the management of this vulnerable patient pop